Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pancreatic Neoplasms 54Carcinoma, Non-Small-Cell Lung 31Lung Neoplasms 23Unspecified Adult Solid Tumor, Protocol Specific 14Urinary Bladder Neoplasms 13Ovarian Neoplasms 12Fallopian Tube Neoplasms 9Lymphoma, Large B-Cell, Diffuse 6Hodgkin Disease 6Breast Neoplasms 6Adenocarcinoma of Lung 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neoplasms 5Lymphoma, Follicular 5Carcinoma, Ovarian Epithelial 5Burkitt Lymphoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, T-Cell, Cutaneous 4Lymphoma, Non-Hodgkin 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Lymphocytic, Chronic, B-Cell 4Colorectal Neoplasms 4Colonic Neoplasms 4Urethral Neoplasms 3Ureteral Neoplasms 3Sezary Syndrome 3Rectal Neoplasms 3Nasopharyngeal Neoplasms 3

Interventions

pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1merphos 1durvalumab 1Vinblastine 1Specimen Handling 1Platinum 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Doxorubicin 1Disulfides 1Cisplatin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Renal Pelvis and Ureter Urothelial Carcinoma × Gemcitabine × Clear all
NCT04628767 2026-06-03

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2/3 Recruiting
131 enrolled
Genitourinary

Renal Pelvis and Ureter Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡